33 / 63
N Median Range
Cycles
45
3.0 (1.0-3.0)
CYCLES
N
%
1
3
5
3
43
95
Total
46
100.0
Neoadjuvant treatment
N %
Complete response (CR)
3 10.0
Partial response (PR)
18 60.0
Stable disease (SD)
9 30.0
Total
30 100.0
Clinical response
No progressive disease has been observed.
All patients received three neoadjuvant cycles
except for the three patients still being treated.